MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q2 2014. The put-call ratio across all filers is 3.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102,110 | -33.7% | 6,366 | -4.1% | 0.00% | – |
Q2 2023 | $153,914 | -4.1% | 6,640 | -3.9% | 0.00% | – |
Q1 2023 | $160,450 | +90.9% | 6,907 | +19.2% | 0.00% | – |
Q4 2022 | $84,056 | -19.9% | 5,793 | +4.6% | 0.00% | – |
Q3 2022 | $105,000 | +2.9% | 5,537 | -1.3% | 0.00% | – |
Q2 2022 | $102,000 | -26.1% | 5,610 | +2.7% | 0.00% | – |
Q1 2022 | $138,000 | -18.3% | 5,463 | -10.4% | 0.00% | – |
Q4 2021 | $169,000 | +6.3% | 6,100 | +23.3% | 0.00% | – |
Q3 2021 | $159,000 | -3.0% | 4,947 | -8.0% | 0.00% | – |
Q2 2021 | $164,000 | +1.2% | 5,378 | +1.3% | 0.00% | – |
Q1 2021 | $162,000 | +78.0% | 5,311 | +13.7% | 0.00% | – |
Q4 2020 | $91,000 | +49.2% | 4,672 | +3.5% | 0.00% | – |
Q3 2020 | $61,000 | +117.9% | 4,516 | +77.1% | 0.00% | – |
Q2 2020 | $28,000 | -62.7% | 2,550 | -51.0% | 0.00% | – |
Q1 2020 | $75,000 | -40.5% | 5,207 | +13.2% | 0.00% | – |
Q4 2019 | $126,000 | +1.6% | 4,600 | +6.2% | 0.00% | – |
Q3 2019 | $124,000 | +39.3% | 4,332 | +37.2% | 0.00% | – |
Q2 2019 | $89,000 | -32.1% | 3,158 | -20.1% | 0.00% | – |
Q1 2019 | $131,000 | +17.0% | 3,950 | +2.0% | 0.00% | – |
Q4 2018 | $112,000 | -44.3% | 3,871 | -11.7% | 0.00% | – |
Q3 2018 | $201,000 | +47.8% | 4,386 | +21.2% | 0.00% | – |
Q2 2018 | $136,000 | +36.0% | 3,618 | +6.4% | 0.00% | – |
Q1 2018 | $100,000 | -18.7% | 3,401 | -5.0% | 0.00% | – |
Q4 2017 | $123,000 | +5.1% | 3,579 | +11.3% | 0.00% | – |
Q3 2017 | $117,000 | +108.9% | 3,217 | +46.7% | 0.00% | – |
Q2 2017 | $56,000 | -84.2% | 2,193 | -88.1% | 0.00% | – |
Q1 2017 | $354,000 | +1375.0% | 18,417 | +1209.9% | 0.00% | – |
Q4 2016 | $24,000 | -25.0% | 1,406 | -12.8% | 0.00% | – |
Q3 2016 | $32,000 | -91.2% | 1,612 | -86.4% | 0.00% | – |
Q2 2016 | $362,000 | -64.2% | 11,868 | -56.0% | 0.00% | -100.0% |
Q1 2016 | $1,010,000 | +60.3% | 26,958 | +85.1% | 0.00% | 0.0% |
Q4 2015 | $630,000 | +22.8% | 14,561 | +6.5% | 0.00% | 0.0% |
Q3 2015 | $513,000 | -35.6% | 13,666 | -41.7% | 0.00% | 0.0% |
Q2 2015 | $797,000 | -2.6% | 23,429 | +1.5% | 0.00% | 0.0% |
Q1 2015 | $818,000 | +15.9% | 23,081 | +11.2% | 0.00% | 0.0% |
Q4 2014 | $706,000 | +2.6% | 20,749 | +16.2% | 0.00% | 0.0% |
Q3 2014 | $688,000 | +81.1% | 17,853 | +82.8% | 0.00% | – |
Q2 2014 | $380,000 | +61.7% | 9,764 | +41.5% | 0.00% | – |
Q1 2014 | $235,000 | +535.1% | 6,902 | +298.5% | 0.00% | – |
Q4 2013 | $37,000 | -64.8% | 1,732 | -61.0% | 0.00% | – |
Q3 2013 | $105,000 | -74.8% | 4,436 | -71.5% | 0.00% | -100.0% |
Q2 2013 | $417,000 | – | 15,562 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |